FLOYE TAYLOR: Open Payments
NPI 1023211521 · BRYANT, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$254 in 13 payments from 6 companies in 2025. Trend: 2023 $649 · 2024 $633 · 2025 $254
Food & beverage: $254
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $106 |
| AstraZeneca Pharmaceuticals LP | 4 | $80 |
| ABBVIE INC. | 1 | $25 |
| PFIZER INC. | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
Products named: CAPLYTA, AIRSUPRA, VRAYLAR, NURTEC ODT, ZEPBOUND, FARXIGA, VOQUEZNA.
Industry payments across AR — which companies pay providers there.
